FDA Investigator Tanya R Syffrard

Tanya R Syffrard has conducted inspections on 26 sites in 2 countries as of 10 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
26
Last Inspection Date:
10 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
100006635
Countries of Inspections:
United States of America, Brazil
FDA Investigators that have inspected at least one site in common with Tanya R Syffrard:
Adetutu M Gidado, Alice S Tsao, Amatul H Marium, Amy C Jordan, Anastasia M Shields, Ankur C Patel, Annet R Rajan, Anthony C Warchut, Anthony Kovalenko, Barbara Jwilimczyk Macri, Bijoy Panicker, Brandy N Lepage, Charanjeet Jassal, Charisse K Green, Christina K Theodorou, Christopher S Fields, Courtney N Long, Dana A Razzano, Daniel J Min, Daryl A Dewoskin, David A Oluwo, David R Delucia, Demitria J Argiropoulos, Demitria J Xiradakis, Diane C Thibodeau, Dien N Nguyen, Dipesh K Shah, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Edward J Janik, Emmanuel Jramos Maldonado, Eric C Schmitt, Erin I Keith, Feiyan Jin, Frederick F Razzaghi, Gabrielle J Swain, Gam S Zamil, Garry H Stewart, Gary J Lehr, Gary T Greco, Guerlain Ulysse, Helen B Ricalde, J'maica J Hunter, James A Liubicich, James R Birkenstamm, Janete F Guardia, Jay T Wong, Jeffrey J Thibodeau, Jogy George, John S Hartford, Johnna L Bleem, Jonathan G Matrisciano, Jose Ohernandez Guzman, Joseph J Vannelli, Joy P Matthias, Juan Rjimenez Garcia, Juanita P Versace, Juliana M Badalucco, Justin A Boyd, Karen L Kosar, Kevin A Gonzalez, Kwong P Lee, Lata C Mathew, PhD, Lawrence W Farina, LCDR Chad N Thompson, Margaret E Sarles, Marie Elena C Puleo, Mark R Mcclain, Maura Rooney, Maya M Davis, Melissa T Roy, Meredith P Soehl, Investigator, Michael A Charles, Michael G Mayfield, Michael G Sinkevich, Mindy M Chou, Nancy F Scheraga, Naveen B Kanthamneni, Nazmul Hassan, Nealie C Newberger, Neil J Bonzagni, PhD MPH, Nerizza B Guerin, Nicholas A Violand, Niketa Patel, Odera I Ekwunife, Paige R Mccoy, Pamela N Agaba, Patrick C Klotzbuecher, Paul E Stein, Paul L Bellamy, Paul Mouris, Peter R Caparelli, Philip F Istafanos, DMV, MS, Puspa Suresh Jayasekara, Raihan A Chowdhury, Rajiv R Srivastava, Rebecca B Welch, Robert C Steyert, Robert J Martin, Robin P Mathew, Rochelle K Kimmel, Rose Ljean Mary, Ruben C Quintana, Russell J Glapion, Samina S Khan, Samuel T Walker, Satheesh Thomas, Sean R Marcsisin, Sena G Dissmeyer, Sony Mathews, Srinivas R Chennamaneni, PhD, Stephen C Smith, Stephen R Souza, Steven M Weinman, Susan M Joseph, Syeda N Mahazabin, Tekalign Wondimu, Terry Bridgewater, Thomas J Mooney, Tomika L Crafter, Tyanna N Hadley, Uduak M Inokon, Vivin George, Xiaojun Yan

Tanya R Syffrard's Documents

Publish Date Document Type Title
July, 2021 EIR LNK International, Inc. - EIR, 2021-07-01
June, 2023 FDA 483 Amware Fulfillment - Form 483, 2023-06-22
November, 2022 FDA 483 Pharbest Pharmaceuticals, Inc. - Form 483, 2022-11-10
September, 2021 FDA 483 SSG Ventures - Form 483, 2021-09-30
August, 2021 FDA 483 Aplicare Products, LLC - Form 483, 2021-08-03
September, 2021 FDA 483 Boothwyn Pharmacy LLC - Form 483, 2021-09-08
March, 2024 FDA 483 Syntho Pharmaceuticals Inc. - Form 483, 2024-03-01
October, 2022 FDA 483 MANA PRODUCTS, INC. - Form 483, 2022-10-17
July, 2021 FDA 483 Response LNK International, Inc. - Form 483R, 2021-07-23
July, 2021 FDA 483 LNK International, Inc. - Form 483, 2021-07-01
May, 2024 FDA 483 CooperSurgical, Inc. - Form 483, 2024-05-21
September, 2023 FDA 483 Ultra Seal Corporation - Form 483, 2023-09-20
March, 2022 FDA 483 Elementis SRL, Inc. - Form 483, 2022-03-17
August, 2022 FDA 483 APPCO PHARMA LLC - Form 483, 2022-08-19
June, 2021 FDA 483 HomeoCare Laboratories Inc. - Form 483, 2021-06-04
January, 2023 FDA 483 AgroChem USA, LLC - Form 483, 2023-01-13
June, 2024 FDA 483 Arzol Chemical Company - Form 483, 2024-06-14
March, 2023 EIR GRANULATION TECHNOLOGY, INC. - EIR, 2023-04-14
July, 2024 FDA 483 Altasciences CDMO Philadelphia - Form 483, 2024-07-26
September, 2022 FDA 483 Precare Corp - Form 483, 2022-09-08
December, 2024 FDA 483 Huber Soda, LLC (DBA Natrium Products) - Form 483, 2024-12-06
February, 2025 FDA 483 Advance Pharmaceutical, Inc. - Form 483, 2025-02-27

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more